Atypical femoral fractures: a complication of prolonged bisphosphonate therapy?
Michael P
MP
Falkenberg
D019386:Alendronate / Q000009:adverse effects*; D050071:Bone Density Conservation Agents / Q000009:adverse effects*; D004164:Diphosphonates / Q000009:adverse effects*; D005264:Femoral Fractures / Q000139:chemically induced*; D006801:Humans
D050071:Bone Density Conservation Agents; D004164:Diphosphonates; D019386:Alendronate